Table 1. Characteristics of the major trials comparing complete revascularization with infarct related artery only revascularization in patients with ST elevation myocardial infarction and multivessel disease.

Trial	Year	N	Complete revascularization approach	Major adverse cardiac events	All-cause mortality	Re-infarction	Urgent revascularization
PRAMI[23]	2013	234/231	Index	21/53	12/16	7/20	16/46
CvLPRIT[24]	2015	150/146	Index (67%), staged prior to hospital discharge (33%)	15/31	2/6	0/2	7/12
DANAMI-3-PRIMULTI[28]	2015	314/313	Staged 2 days after index PCI	40/68	15/11	15/16	17/52
COMPARE-ACUTE[29]	2017	295/590	Index (83%), staged prior to hospital discharge (17%)	23/121	4/10	7/28	18/103
COMPLETE[35]	2019	2016/2025	Staged: 64% prior to discharge (median 1 day), 36% after discharge (median 23 days)	179/339	96/106	109/160	29/160

Events in complete revascularization/Events in infarct related artery only revascularization.